U.S. Business Unit Product Portfolio

Committed to better health for individuals, Takeda in the U.S. markets innovative pharmaceutical treatments. To learn more about our oncology products, visit www.takedaoncology.com. Click on the product links for more detailed information on our other U.S. marketed products.

In addition to our on-the-market products, Takeda invests in an active R&D pipeline in an effort to bring new treatments to patients in need. Click here  for more information on our global R&D pipeline.

 

Brand Name Generic Name Prescribing Information
ACTOS pioglitazone Click here for Prescribing Information including boxed warning and medication guide
ACTOplus met pioglitazone and metformin HCl Click here for Prescribing Information including boxed warning and medication guide
ACTOplus met XR pioglitazone and metformin HCl 
(extended release)
Click here for Prescribing Information including boxed warning and medication guide
Duetact pioglitazone and glimepiride Click here for Prescribing Information including boxed warning and medication guide
AMITIZA lubiprostone Click here for Prescribing Information
COLCRYS colchicine, USP Click here for Prescribing Information including medication guide

DEXILANT 

dexlansoprazole Click here for Prescribing Information including medication guide
ENTYVIO vedolizumab Click here for Prescribing Information including medication guide
KAZANO alogliptin and metformin HCl Click here for Prescribing Information including boxed warning, and medication guide
NESINA alogliptin Click here for Prescribing Information including medication guide
OSENI alogliptin and pioglitazone Click here for Prescribing Information including boxed warning and medication guide

PREVACID

PREVACID SOLUTAB

lansoprazole Click here for Prescribing Information including medication guide
PREVPAC lansoprazole
/amoxicillin
/clarithromycin
Click here for Prescribing Information
ROZEREM ramelteon Click here for Prescribing Information including medication guide
TRINTELLIX vortioxetine Click here for Prescribing Information including boxed warning and medication guide
ULORIC febuxostat Click here for Prescribing Information

 

ACTOS, ACTOplus met, ACTOplus met XR, and Duetact are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

AMITIZA is a trademark of Sucampo Pharmaceuticals, Inc. registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

COLCRYS is a trademark of Takeda Pharmaceuticals U.S.A., Inc., registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

DEXILANT and DEXILANT (with design) are trademarks of Takeda Pharmaceuticals U.S.A., Inc., registered in the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

ENTYVIO is a trademark of Millennium Pharmaceuticals Inc., registered with the U.S. Patent and Trademark Office and is used under license by Takeda Pharmaceuticals America, Inc.

KAZANO is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

NESINA is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

OSENI is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

PREVACID is a trademark registered in the U.S. Patent and Trademark Office and SoluTab is a trademark of Takeda Pharmaceuticals U. S. A., Inc. and used under license by Takeda Pharmaceuticals America, Inc.

PREVPAC is a trademark of Takeda Pharmaceuticals U. S. A., Inc. registered in the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

Rozerem is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

TRINTELLIX is a trademark of H. Lundbeck A/S and used under license by Takeda Pharmaceuticals America, Inc.

ULORIC is a trademark of Teijin Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.